Table 1. Patient clinical characteristics (n=32).
| Characteristic | Value | Number of patients | % |
|---|---|---|---|
| Age, years | |||
| Median (range) | 27.5 (15-61) | ||
| ≥35 | 11 | 34.4 | |
| <35 | 21 | 65.6 | |
| WBC(×109/L) Median (range) | 46.3 (1.3-429.5) | ||
| ≥30 | 22 | 68.8 | |
| <30 | 10 | 31.2 | |
| LDH | |||
| High | 22 | 68.8 | |
| Normal | 10 | 34.4 | |
| Status of d14 | |||
| CR | 20 | 62.5 | |
| NR | 12 | 31.2 | |
| Status after induction therapy | |||
| CR | 25 | 78.1 | |
| NR | 7 | 21.9 | |
| Extramedullary infiltration | |||
| Yes | 24 | 75 | |
| No | 8 | 25 | |
| Immune phenotype | |||
| Pro-B | 13 | 40.6 | |
| Non-proB | 19 | 59.4 | |
| Risk category | |||
| High | 13 | 40.6 | |
| Standard | 19 | 59.4 | |
| Ph chromosome | |||
| Positive | 11 | 34.4 | |
| Negative | 21 | 65.6 | |
| p16 gene deletion | |||
| Positive | 12 | 42.9 | |
| Negative | 16 | 57.1 |
Abbreviations: WBC, white blood cell; LDH, lactic dehydrogenase; CR, complete remission; NR, No remission.